|
Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia |
Visconti AJ, Doyle JS, Weir A, Shiell AM, Hellard ME |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Visconti AJ, Doyle JS, Weir A, Shiell AM, Hellard ME. Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia. Journal of Gastroenterology and Hepatology 2013; 28(4): 707-716 Indexing Status Subject indexing assigned by NLM MeSH Adult; Antiviral Agents /economics /therapeutic use; Australia; Cohort Studies; Cost-Benefit Analysis; Drug Therapy, Combination /economics; Early Medical Intervention; Female; Hepatitis C, Chronic /drug therapy /economics; Humans; Interferon-alpha /economics /therapeutic use; Male; Markov Chains; Models, Statistical; Polyethylene Glycols /economics /therapeutic use; Quality-Adjusted Life Years; Recombinant Proteins /economics /therapeutic use; Ribavirin /economics /therapeutic use; Substance Abuse, Intravenous /economics; Victoria AccessionNumber 22013016761 Date bibliographic record published 07/06/2013 |
|
|
|